Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247883 · ClinicalTrials.gov registry record · Phase 1
A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01247883 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 13 participants.
The verdict
NCT01247883, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study investigates the safety, tolerability and pharmacokinetics of PF-04634817 when respectively given orally as a single tablet dose and a single dose of a solution.
Interventions
- DRUG PF-04634817
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-10 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01247883
The ClinicalTrials.gov registry entry for NCT01247883 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-04634817 is the first listed.
NCT01247883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01247883 about?
NCT01247883 is a clinical study titled "A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers". This study investigates the safety, tolerability and pharmacokinetics of PF-04634817 when respectively given orally as a single tablet dose and a single dose of a solution.
What is the current status of trial NCT01247883?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2010-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01247883?
The interventions under investigation include: PF-04634817 (DRUG).
Who is sponsoring clinical trial NCT01247883?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.